QUOTE AND NEWS
FierceBiotech  3 hrs ago  Comment 
Johnson & Johnson, fighting to keep up with the blockbuster race to launch quick cures for hepatitis C, has agreed to pay as much as $1.1 billion for the rights to Achillion Pharmaceuticals' pipeline of antiviral treatments.
Reuters  4 hrs ago  Comment 
Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and...
TheStreet.com  May 19  Comment 
BOSTON (TheStreet) -- For a brief moment, and mostly on Twitter, Gilead Sciences was buying Achillion Pharmaceuticals . The speculation of another hepatitis C-related acquisition took off Monday afternoon, sparked by a rumor that Gilead...
Motley Fool  May 18  Comment 
Achillion Pharmaceuticals shares are heading higher on hopes that a suitor may emerge.
Market Intelligence Center  Apr 10  Comment 
After Thursday’s trading in Achillion Pharmaceuticals, Inc. (ACHN) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 14.38% or 18.74% (for comparison purposes only), while providing 40.12% downside...
Benzinga  Apr 9  Comment 
In a report published Thursday, JMP Securities analysts expressed their views on Biotechnology stocks after the EASL abstracts were made available ahead of the European liver meeting. The analysts have a Market Perform rating on Merck & Co. Inc...





You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki